Roswell Park Cancer Institute to Conduct First CimaVax Trial in the United States
By Cynthia L. Kryder, MS Roswell Park Cancer Institute in Buffalo, New York, US, expects to be the site for the first US clinical trial of CimaVax, the groundbreaking lung […] Read more
By Beth Eaby-Sandy, MSN, CRNP, OCN, Massey Nematollahi, RN, MScN, OCN, CON, Diana Borthwick, MSc, PGD, and Beth Ivimey, RN United States of America There are now 2 distinct immunotherapy […] Read more
By Kenneth Michael Cummings, PhD, MPH The US FDA recently finalized a new rule (http://www.fda.gov/TobaccoProducts/ Labeling/RulesRegulationsGuidance/ ucm388395.htm) that will extend its regulatory authority to all tobacco products, including small and […] Read more
Dear Colleagues, IASLC WCLC 2016, with the theme “Active Prevention, Accurate Diagnosis, Advanced Care,” will be a multidisciplinary conference covering all aspects of lung cancer. The conference will inform participants […] Read more
By Erik J. MacLaren, PhD Osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), received FDA approval in November 2015 for use in patients with metastatic EGFR […] Read more
The Victorian Comprehensive Cancer Centre, which opened this summer, is a new purpose-built facility for cancer research, treatment, care, and education in Melbourne’s Parkville biomedical precinct. In addition to the […] Read more
By Erik J. MacLaren, PhD Alectinib is a second-generation anaplastic lymphoma kinase (ALK) inhibitor that was recently approved in the US as a second- line treatment for ALK-rearranged non-small cell […] Read more
By Denise R. Aberle, MD The seminal National Lung Screening Trial (NLST) showed that lung cancer screening using low dose computed tomography (LDCT) resulted in a 20% decrease in lung […] Read more
By Peter Ujhazy, MD, PhD The newfound optimism in the management of lung cancer that infused the research, clinical, and patient communities 12 years ago is still gaining momentum. Seminal […] Read more
2016 ASCO Annual Meeting
By Erik J. MacLaren, PhD This year’s annual meeting of the American Society of Clinical Oncology (ASCO) is taking place June 3–7 in Chicago. The theme of the meeting this […] Read more